Quality of life and its association with insight, adverse effects of medication and use of atypical antipsychotics in patients with bipolar disorder and schizophrenia in remission

Bipolar Disorders

Volumn 10, Issue 5, 2008, Pages 617-624

  Yen, Cheng Fang ^a,b   Cheng, Chung Ping ^c   Huang, Chi Fen ^a   Yen, Ju Yu ^a,b,d   Ko, Chih Hung ^a,b   Chen, Cheng Sheng ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Adverse effects of medication; Antipsychotic; Bipolar disorder; Insight schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; HUMAN RELATION; INTROSPECTION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATIENT CARE; PATIENT COMPLIANCE; PHYSICAL CAPACITY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SCHIZOPHRENIA; SOCIAL ASPECT; SOCIAL SUPPORT; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADULT; ANTIPSYCHOTIC AGENTS; AWARENESS; BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TAIWAN; TREATMENT OUTCOME;

EID: 47649089897     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00577.x     Document Type: Article

References (56)

1. Stastney P, Amering M. Integrating consumer perspectives on quality of life in research and service planning. In: Katschnig H, Freeman H, Sartorius N eds. Quality of Life in Mental Disorders. Chichester: John Wiley & Sons, 1997: 261-269.
2. Albrecht GL, Fitzpatrick R. A sociological perspective on health-related quality of life research. In: Albrecht GL, Fitzpatrick R eds. Advances in Medical Sociology, Volume 5, Quality of Life in Health Care. London: Jai Press, 1994: 1-21.
3. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand 2000; 102(Suppl. 407): 33-37.
4. Michalak EE, Yatham LN, Lam RW. Quality of life in bipolar disorder: A review of the literature. Health Qual Life Outcomes 2005; 3: 72.
5. Bobes J, Gonzales MP. Quality of life in schizophrenia. In: Katschnig H, Freeman H, Sartorius N eds. Quality of Life in Mental Disorders. New York, NY: John Wiley & Sons, 1997: 165-178.
6. Yatham LN, Lecrubier Y, Fieve RR, Davis KH, Harris SD, Krishnan AA. Quality of life in patients with bipolar I depression: Data from 920 patients. Bipolar Disord 2004; 6: 379-385.
7. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology. Am J Psychiatry 1997; 154: 99-105.
8. Ritsner M, Modai I, Endicott J et al. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000; 61: 880-889.
9. Gazalle FK, Frey BN, Hallal PC et al. Mismatch between self-reported quality of life and functional assessment in acute mania: A matter of unawareness of illness. J Affect Disord 2007; 103: 247-252.
10. Vojta C, Kinosian B, Glick H, Altshuler L, Bauer MS. Self-reported quality of life across mood states in bipolar disorder. Compr Psychiatry 2001; 42: 190-195.
11. Reine G, Lancon C, Di Tucci S, Sapin C, Auquier P. Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr Scand 2003; 108: 297-303.
12. David AS. The clinical importance of insight: An overview. In: Amador XF, David AS eds. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders. New York, NY: Oxford University Press, 2004: 359-391.
13. Yen CF, Chen CS, Yeh ML, Yen JY, Ker JH, Yang SJ. Comparison of insight in patients with schizophrenia and bipolar disorder in remission. J Nerv Ment Dis 2002; 90: 847-849.
14. Browne S, Garavan J, Gervin M, Roe M, Larkin C, O'Callaghan E. Quality of life in schizophrenia: Insight and subjective response to neuroleptics. J Nerv Ment Dis 1998; 186: 74-78.
15. Holloway F, Carson J. Subjective quality of life, psychopathology, satisfaction with care and insight: An exploratory study. Int J Soc Psychiatry 1999; 45: 259-267.
16. Smith TE, Hull JW, Goodman M et al. The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis 1999; 187: 102-108.
17. Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M. Insight into psychosis and quality of life. Compr Psychiatry 2006; 47: 265-269.
18. Ritsner M. The attribution of somatization in schizophrenia patients: A naturalistic follow-up study. J Clin Psychiatry 2003; 64: 1370-1378.
19. MacQueen GM, Young LT, Robb JC, Cooke RG, Joffe RT. Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. J Affect Disord 1997; 46: 69-72.
20. Morselli PL, Elgie R, Cesana BM. GAMIAN-Europe/BEAM survey II: cross-national analysis of unemployment, family history, treatment satisfaction and impact of the bipolar disorder on life style. Bipolar Disord 2004; 6: 487-497.
21. McIntyre JS, Charles SC. Practice Guidelines for the Treatment of Psychiatric Disorders. Washington, DC: APA, 2002.
22. Taylor D, Paton C, Kerwin R. The South London and Maudsley NHS Trust & Oxleas NHS Trust: 2005-2006 Prescribing Guidelines. London: Taylor & Francis, 2005.
23. Browne S, Roe M, Lane A et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta Psychiatr Scand 1996; 94: 118-124.
24. Young AS, Sullivan G, Burnam MA. Measuring the quality of outpatient treatment for schizophrenia. Arch Rev Psychiatry 1998; 28: 1221-1230.
25. Yatham LN. Atypical antipsychotics for bipolar disorder. Psychiatr Clin North Am 2005; 28: 325-347.
26. Kinon BJ, Noordsy DL, Liu-Seifert H, Gulliver AH, Ascher-Svanum H, Kollack-Walker S. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning. J Clin Psychopharmacol 2006; 26: 453-461.
27. Jones PB, Barnes TR, Davies L et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost utility of the latest antipsychotic drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006; 63: 1079-1087.
28. Lewis SW, Barnes TR, Davies L et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 2006; 32: 715-723.
29. Ritsner MS, Gibel A. The effectiveness and predictors of response to antipsychotic agents to treat impaired quality of life in schizophrenia: a 12-month naturalistic follow-up study with implications for confounding factors, antidepressants, anxiolytics, and mood stabilizers. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 1442-1452.
30. Silva de Lima M, de Jesus Mari J, Breier A, Maria Costa A, Ponde de Sena E, Hotopf M. Quality of life in schizophrenia: A multicenter, randomized, naturalistic, controlled trial comparing olanzapine to first-generation antipsychotics. J Clin Psychiatry 2005; 66: 831-838.
31. Taniguchi T, Sumitani S, Aono M et al. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms. Hum Psychopharmacol 2006; 21: 439-445.
32. Endicott J, Rajagopalan K, Minkwitz M, Macfadden W, BOLDER Study Group. A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: Improvements in quality of life. Int Clin Psychopharmacol 2007; 22: 29-37.
33. Vornik LA, Hirschfeld RM. Bipolar disorder: Quality of life and the impact of atypical antipsychotics. Am J Manag Care 2005; 11(Suppl. 9): 275-280.
34. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int Clin Psychopharmacol 1995; 10(Suppl. 3): 133-138.
35. American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders. Washington, DC: American Psychiatric Association, 1994.
36. Cheng JJ, Ho H, Chang CJ, Lan SY, Hwu HG. Positive and Negative Syndrome Scale (PANSS): Establishment and reliability study of a Mandarin Chinese language version. Chin Psychiatry ROC 1996; 10: 251-258.
37. Kay SR. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. New York: Brunner/Mazel, 1991.
38. Young R, Biggs J, Meyer D. A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
39. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
40. Altshuler L, Mintz J, Leight K. The Life Functioning Questionnaire (LFQ): A brief, gender-neutral scale assessing functional outcome. Psychiatry Res 2002; 112: 161-182.
41. Yen CF, Chen CS, Ko CH, Yen JY, Huang CF. Changes in insight among patients with bipolar I disorder: A two-year prospective study. Bipolar Disord 2007; 9: 238-242.
42. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551-558.
43. Yao G, Chung CW, Yu CF, Wang JD. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 2002; 101: 342-351.
44. Kemp R, David A. Insight and compliance. In: Blackwell B ed. Treatment Compliance and the Therapeutic Alliance. Newark, NJ: Gordon and Breach Publishing Group, 1996: 61-84.
45. Wang YH. Study on life quality and its associated factors of rheumatoid arthritis patients. J Chang Gung Institute Technol 1999; 2: 108-120.
46. Barrera M, Sandler I. Preliminary development of a scale of social support: Studies on college students. Am J Community Psychol 1981; 9: 435-447.
47. Yen CF, Chen CS, Ko CH et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: A prospective study. Psychiatry Clin Neurosci 2005; 59: 403-409.
48. Depp CA, Davis CE, Mittal D, Patterson TL, Jeste DV. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder. J Clin Psychiatry 2006; 67: 215-221.
49. Michalak EE, Yatham LN, Kolesar S, Lam RW. Bipolar disorder and quality of life: A patient-centered perspective. Qual Life Res 2006; 15: 25-37.
50. Warner R. Recovery From Schizophrenia: Psychiatry and Political Economy, 2nd edn. New York, NY: Routledge, 1994.
51. Corrigan P, Thompson V, Lambert D, Sangster Y, Noel JG, Campbell J. Perceptions of discrimination among persons with serious mental illness. Psychiatr Serv 2003; 54: 1105-1110.
52. Cooper AE, Corrigan PW, Watson AC. Mental illness stigma and care seeking. J Nerv Ment Dis 2003; 191: 339-341.
53. Awade AG, Hogan TP. Subjective response to neuroleptics and quality of life: Implications for treatment outcome. Acta Psychiatr Scand 1994; 89(Suppl. 380): 27-31.
54. Kilian R, Angermeyer MC. The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: An application of random effect regression models and propensity scores in an observational prospective trial. Qual Life Res 2005; 14: 1275-1289.
55. Namjoshi MA, Risser R, Shi L, Tohen M, Breier A. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid. J Affect Disord 2004; 81: 223-229.
56. Shi L, Namjoshi MA, Zhang F et al. Olanzapine versus haloperidol in the treatment of acute mania: Clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17: 227-237.